Supplementary Table 2 from Targeting CD44 Variant 5 with an Antibody–Drug Conjugate Is an Effective Therapeutic Strategy for Intrahepatic Cholangiocarcinoma
<p>amino acid sequences of mAbs in this study</p>
সংরক্ষণ করুন:
| প্রধান লেখক: | |
|---|---|
| অন্যান্য লেখক: | , , , , , , , , , , |
| প্রকাশিত: |
2025
|
| বিষয়গুলি: | |
| ট্যাগগুলো: |
ট্যাগ যুক্ত করুন
কোনো ট্যাগ নেই, প্রথমজন হিসাবে ট্যাগ করুন!
|
| _version_ | 1849927639203053568 |
|---|---|
| author | Yuncheng Bei (16546095) |
| author2 | Jian He (16546098) Xuhui Dong (16546101) Yuxin Wang (16546104) Sijie Wang (16546107) Wan Guo (16546110) Chengjie Cai (16546113) Zhiye Xu (16546116) Jia Wei (11469308) Baorui Liu (15134681) Nan Zhang (16546119) Pingping Shen (16546122) |
| author2_role | author author author author author author author author author author author |
| author_facet | Yuncheng Bei (16546095) Jian He (16546098) Xuhui Dong (16546101) Yuxin Wang (16546104) Sijie Wang (16546107) Wan Guo (16546110) Chengjie Cai (16546113) Zhiye Xu (16546116) Jia Wei (11469308) Baorui Liu (15134681) Nan Zhang (16546119) Pingping Shen (16546122) |
| author_role | author |
| dc.creator.none.fl_str_mv | Yuncheng Bei (16546095) Jian He (16546098) Xuhui Dong (16546101) Yuxin Wang (16546104) Sijie Wang (16546107) Wan Guo (16546110) Chengjie Cai (16546113) Zhiye Xu (16546116) Jia Wei (11469308) Baorui Liu (15134681) Nan Zhang (16546119) Pingping Shen (16546122) |
| dc.date.none.fl_str_mv | 2025-11-24T23:01:00Z |
| dc.identifier.none.fl_str_mv | 10.1158/0008-5472.30699892 |
| dc.relation.none.fl_str_mv | https://figshare.com/articles/dataset/Supplementary_Table_2_from_Targeting_CD44_Variant_5_with_an_Antibody_Drug_Conjugate_Is_an_Effective_Therapeutic_Strategy_for_Intrahepatic_Cholangiocarcinoma/30699892 |
| dc.rights.none.fl_str_mv | CC BY info:eu-repo/semantics/openAccess |
| dc.subject.none.fl_str_mv | Cancer Therapeutic Research and Development Methods and Technology Biological Agents & Therapies Antibody-drug conjugates Computational Methods Database resources Drug Targets Cell surface receptor drug targets Preclinical Models Xenograft models |
| dc.title.none.fl_str_mv | Supplementary Table 2 from Targeting CD44 Variant 5 with an Antibody–Drug Conjugate Is an Effective Therapeutic Strategy for Intrahepatic Cholangiocarcinoma |
| dc.type.none.fl_str_mv | Dataset info:eu-repo/semantics/publishedVersion dataset |
| description | <p>amino acid sequences of mAbs in this study</p> |
| eu_rights_str_mv | openAccess |
| id | Manara_e7c480953c70b665433ca13881bafcd3 |
| identifier_str_mv | 10.1158/0008-5472.30699892 |
| network_acronym_str | Manara |
| network_name_str | ManaraRepo |
| oai_identifier_str | oai:figshare.com:article/30699892 |
| publishDate | 2025 |
| repository.mail.fl_str_mv | |
| repository.name.fl_str_mv | |
| repository_id_str | |
| rights_invalid_str_mv | CC BY |
| spelling | Supplementary Table 2 from Targeting CD44 Variant 5 with an Antibody–Drug Conjugate Is an Effective Therapeutic Strategy for Intrahepatic CholangiocarcinomaYuncheng Bei (16546095)Jian He (16546098)Xuhui Dong (16546101)Yuxin Wang (16546104)Sijie Wang (16546107)Wan Guo (16546110)Chengjie Cai (16546113)Zhiye Xu (16546116)Jia Wei (11469308)Baorui Liu (15134681)Nan Zhang (16546119)Pingping Shen (16546122)CancerTherapeutic Research and DevelopmentMethods and TechnologyBiological Agents & TherapiesAntibody-drug conjugatesComputational MethodsDatabase resourcesDrug TargetsCell surface receptor drug targetsPreclinical ModelsXenograft models<p>amino acid sequences of mAbs in this study</p>2025-11-24T23:01:00ZDatasetinfo:eu-repo/semantics/publishedVersiondataset10.1158/0008-5472.30699892https://figshare.com/articles/dataset/Supplementary_Table_2_from_Targeting_CD44_Variant_5_with_an_Antibody_Drug_Conjugate_Is_an_Effective_Therapeutic_Strategy_for_Intrahepatic_Cholangiocarcinoma/30699892CC BYinfo:eu-repo/semantics/openAccessoai:figshare.com:article/306998922025-11-24T23:01:00Z |
| spellingShingle | Supplementary Table 2 from Targeting CD44 Variant 5 with an Antibody–Drug Conjugate Is an Effective Therapeutic Strategy for Intrahepatic Cholangiocarcinoma Yuncheng Bei (16546095) Cancer Therapeutic Research and Development Methods and Technology Biological Agents & Therapies Antibody-drug conjugates Computational Methods Database resources Drug Targets Cell surface receptor drug targets Preclinical Models Xenograft models |
| status_str | publishedVersion |
| title | Supplementary Table 2 from Targeting CD44 Variant 5 with an Antibody–Drug Conjugate Is an Effective Therapeutic Strategy for Intrahepatic Cholangiocarcinoma |
| title_full | Supplementary Table 2 from Targeting CD44 Variant 5 with an Antibody–Drug Conjugate Is an Effective Therapeutic Strategy for Intrahepatic Cholangiocarcinoma |
| title_fullStr | Supplementary Table 2 from Targeting CD44 Variant 5 with an Antibody–Drug Conjugate Is an Effective Therapeutic Strategy for Intrahepatic Cholangiocarcinoma |
| title_full_unstemmed | Supplementary Table 2 from Targeting CD44 Variant 5 with an Antibody–Drug Conjugate Is an Effective Therapeutic Strategy for Intrahepatic Cholangiocarcinoma |
| title_short | Supplementary Table 2 from Targeting CD44 Variant 5 with an Antibody–Drug Conjugate Is an Effective Therapeutic Strategy for Intrahepatic Cholangiocarcinoma |
| title_sort | Supplementary Table 2 from Targeting CD44 Variant 5 with an Antibody–Drug Conjugate Is an Effective Therapeutic Strategy for Intrahepatic Cholangiocarcinoma |
| topic | Cancer Therapeutic Research and Development Methods and Technology Biological Agents & Therapies Antibody-drug conjugates Computational Methods Database resources Drug Targets Cell surface receptor drug targets Preclinical Models Xenograft models |